Variant report
Variant | esv3519034 |
---|---|
Chromosome Location | chr6:165723412-165733360 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:5)
- CpG islands (count:183)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:5 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | JUND | chr6:165733281-165733292 | K562 | blood: | n/a | n/a |
2 | MXI1 | chr6:165722399-165723472 | SK-N-SH | brain: | n/a | chr6:165723107-165723122 chr6:165723109-165723124 |
3 | REST | chr6:165730351-165730533 | H1-hESC | embryonic stem cell: | n/a | chr6:165730431-165730441 chr6:165730435-165730444 |
4 | REST | chr6:165730334-165730521 | H1-hESC | embryonic stem cell: | n/a | chr6:165730431-165730441 chr6:165730435-165730444 |
5 | STAT3 | chr6:165723521-165723608 | MCF10A-Er-Src | breast: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:165723708-165723758 | A549 | lung: | n/a |
2 | chr6:165723708-165723758 | HCT-116 | colon: | n/a |
3 | chr6:165723796-165723846 | HRE | kidney: | n/a |
4 | chr6:165723796-165723846 | RPTEC | kidney: | n/a |
5 | chr6:165724355-165724405 | LNCaP | prostate: | n/a |
6 | chr6:165723796-165723846 | K562 | blood: | n/a |
7 | chr6:165723708-165723758 | BJ | skin: | n/a |
8 | chr6:165723708-165723758 | AG04450 | lung: | fetal |
9 | chr6:165723708-165723758 | AG09319 | gingival: | n/a |
10 | chr6:165724355-165724405 | SKMC | muscle: | n/a |
11 | chr6:165723796-165723846 | CMK | blood: | n/a |
12 | chr6:165723708-165723758 | GM19239 | blood: | n/a |
13 | chr6:165723796-165723846 | GM12892 | blood: | n/a |
14 | chr6:165723708-165723758 | PFSK-1 | brain: | n/a |
15 | chr6:165723796-165723846 | Caco-2 | colon: | n/a |
16 | chr6:165724355-165724405 | MCF-7 | breast: | n/a |
17 | chr6:165723708-165723758 | HRE | kidney: | n/a |
18 | chr6:165723708-165723758 | HCF | heart: | n/a |
19 | chr6:165723796-165723846 | HNPCEpiC | eye: | n/a |
20 | chr6:165723708-165723758 | NH-A | brain: | n/a |
21 | chr6:165723796-165723846 | NHDF-neo | bronchial: | n/a |
22 | chr6:165723708-165723758 | AoSMC | blood vessel: | n/a |
23 | chr6:165723796-165723846 | A549 | lung: | n/a |
24 | chr6:165723796-165723846 | IMR90 | lung: | fetal |
25 | chr6:165723708-165723758 | SK-N-MC | brain: | n/a |
26 | chr6:165723708-165723758 | GM12878 | blood: | n/a |
27 | chr6:165724355-165724405 | K562 | blood: | n/a |
28 | chr6:165723708-165723758 | HEEpiC | esophagus: | n/a |
29 | chr6:165724355-165724405 | BJ | skin: | n/a |
30 | chr6:165723796-165723846 | T-47D | breast: | n/a |
31 | chr6:165723796-165723846 | AG09309 | skin: | n/a |
32 | chr6:165723796-165723846 | H1-hESC | embryonic stem cell: | embryo |
33 | chr6:165723708-165723758 | NHBE | bronchial: | n/a |
34 | chr6:165724355-165724405 | GM12878 | blood: | n/a |
35 | chr6:165724355-165724405 | NT2-D1 | testis: | n/a |
36 | chr6:165723708-165723758 | LNCaP | prostate: | n/a |
37 | chr6:165724355-165724405 | GM06990 | blood: | n/a |
38 | chr6:165723796-165723846 | HPAEpiC | pulmonary alveolar: | n/a |
39 | chr6:165724355-165724405 | HAEpiC | amniotic membrane: | n/a |
40 | chr6:165723708-165723758 | MCF10A-Er-Src | breast: | n/a |
41 | chr6:165723796-165723846 | HCPEpiC | choroid plexus: | n/a |
42 | chr6:165723708-165723758 | Hela-S3 | cervix: | n/a |
43 | chr6:165723708-165723758 | ProgFib | skin: | n/a |
44 | chr6:165723708-165723758 | HRPEpiC | eye: | n/a |
45 | chr6:165723708-165723758 | GM12891 | blood: | n/a |
46 | chr6:165723708-165723758 | GM06990 | blood: | n/a |
47 | chr6:165723708-165723758 | IMR90 | lung: | fetal |
48 | chr6:165724355-165724405 | HCF | heart: | n/a |
49 | chr6:165723796-165723846 | SK-N-SH | brain: | n/a |
50 | chr6:165724355-165724405 | HRCEpiC | kidney: | n/a |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
C6orf118 | TF binding region |
C6orf118 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs147851069 | chr6:165723442-165723443 | Enhancers Flanking Active TSS Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs578066 | chr6:165723449-165723450 | Enhancers Flanking Active TSS Weak transcription Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs368223684 | chr6:165723472-165723473 | Enhancers Flanking Active TSS Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs621122 | chr6:165723485-165723486 | Enhancers Flanking Active TSS Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs182478454 | chr6:165723508-165723509 | Enhancers Flanking Active TSS Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs185742396 | chr6:165723517-165723518 | Enhancers Flanking Active TSS Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs573635427 | chr6:165723532-165723533 | Enhancers Flanking Active TSS Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs140291254 | chr6:165723537-165723538 | Enhancers Flanking Active TSS Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs537677585 | chr6:165723556-165723557 | Enhancers Flanking Active TSS Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs386708347 | chr6:165723559-165723560 | Enhancers Flanking Active TSS Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs508897 | chr6:165723568-165723569 | Enhancers Flanking Active TSS Weak transcription Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs573795856 | chr6:165723653-165723654 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs508041 | chr6:165723655-165723656 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs374075131 | chr6:165723707-165723708 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs201581876 | chr6:165723717-165723718 | Enhancers Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs76782633 | chr6:165723719-165723720 | Enhancers Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs397886038 | chr6:165723720-165723721 | Enhancers Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs556325981 | chr6:165723761-165723762 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs7761386 | chr6:165723762-165723763 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs376464736 | chr6:165723769-165723770 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs369972666 | chr6:165723839-165723840 | Enhancers Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs201046377 | chr6:165723894-165723895 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs386708348 | chr6:165723895-165723896 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs201844147 | chr6:165723896-165723897 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs199999519 | chr6:165723897-165723898 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs563929724 | chr6:165723925-165723926 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs189081458 | chr6:165723934-165723935 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs181123749 | chr6:165723971-165723972 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs539838012 | chr6:165724011-165724012 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs558067528 | chr6:165724039-165724040 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs528974699 | chr6:165724040-165724041 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs504371 | chr6:165724052-165724053 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs504349 | chr6:165724060-165724061 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs185664653 | chr6:165724064-165724065 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs112774052 | chr6:165724111-165724112 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs551602492 | chr6:165724117-165724118 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs566759243 | chr6:165724151-165724152 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs617910 | chr6:165724152-165724153 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs149941574 | chr6:165724222-165724223 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs76785996 | chr6:165724238-165724239 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs191450789 | chr6:165724270-165724271 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs577468041 | chr6:165724295-165724296 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs144938119 | chr6:165724298-165724299 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs386708349 | chr6:165724325-165724326 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs182348575 | chr6:165724326-165724327 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs501712 | chr6:165724332-165724333 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs554490972 | chr6:165724362-165724363 | Enhancers Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs572647274 | chr6:165724388-165724389 | Enhancers Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs555124698 | chr6:165724402-165724403 | Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs149065999 | chr6:165724505-165724506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
Chordoma | 18071362 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
abnormal development | 18461090 | CNVD |
Epilepsy | 22083797 | CNVD |
Myelofibrosis | 22110671 | CNVD |
chordoma | 19801981 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Autism | 17483303 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 22522925 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:165722800-165723600 | Active TSS | Brain Dorsolateral Prefrontal Cortex | brain |
2 | chr6:165723000-165724400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
3 | chr6:165723200-165723600 | Enhancers | Fetal Lung | lung |
4 | chr6:165723200-165723600 | Enhancers | Stomach Smooth Muscle | stomach |
5 | chr6:165723200-165723800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr6:165723200-165723800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
7 | chr6:165723200-165723800 | Enhancers | Rectal Smooth Muscle | rectum |
8 | chr6:165723200-165726000 | Weak transcription | Right Atrium | heart |
9 | chr6:165723200-165733800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
10 | chr6:165723400-165723600 | Flanking Active TSS | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr6:165723400-165723600 | Enhancers | Brain Germinal Matrix | brain |
12 | chr6:165723400-165723800 | Enhancers | Brain Cingulate Gyrus | brain |
13 | chr6:165723400-165723800 | Enhancers | Brain Hippocampus Middle | brain |
14 | chr6:165723400-165724000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
15 | chr6:165723400-165724000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
16 | chr6:165723600-165723800 | Enhancers | Fetal Stomach | stomach |
17 | chr6:165723600-165724000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
18 | chr6:165723600-165724000 | Enhancers | Fetal Brain Female | brain |
19 | chr6:165724000-165724200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
20 | chr6:165724000-165725000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
21 | chr6:165730000-165730600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
22 | chr6:165730400-165731200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |